CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC

112 participants · First posted Sep 20, 2019

SAlt Diet and Various Biomarkers Effects on Blood Pressure and Proteinuria During Inhibition of VEGF)

26 participants · First posted Feb 15, 2019

Abraxane/Bevacizumab

5 participants · First posted Apr 1, 2013

Bevacizumab(Avastin, Mvasi, Oyavas, Alymsys, Aybintio, Abevmy, Vegzelma, Onbevzi, Zirabev, Lytenava, Avzivi, Lextemy, Ipique)

Rx

bevacizumab-800CW

bevacizumab-ADNAB

Outlook Therapeutics

United States

Bio-Thera Solutions, Ltd.

HENLIUS

China

FDA Approves Biocon Biologics' Bevacizumab Biosimilar JOBEVNE for Multiple Cancer Indications

FDA Phases Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

Biocon Reports 15% Revenue Growth in Q4FY25, Launches Fifth Biosimilar in U.S. Market